Intermediates of Raltegravir, offered by us can be seen from the list shown below. Please click on the Intermediate name to browse through more details of the intermediate required by you. If you can not locate your required intermediate for Raltegravir on this page, you may send us a sourcing request for the specific Raltegravir intermediate you are looking for along with its Cas No, and the Intermediate name and we shall come back to you promptly with more details.
Raltegravir is an antiviral medicine that prevents human immunodeficiency virus(HIV) from multiplying in your body. Raltegravir is used to treat HIV, the virus that can cause acquired immunodeficiency syndrome (AIDS). Raltegravir is not a cure for HIVor AIDS.
Integration of the HIV-1 viral DNA generated by reverse transcription of the RNA genome into the host cell chromosomes is a key step of viral replication, catalyzed by the viral integrase. In October 2007, the first integrase inhibitor, raltegravir, was approved for clinical use under the name of Isentress. The results of the various clinical trials that have evaluated raltegravir have been very encouraging with regard to the immunological and virological efficacy and tolerance. However, as observed for other anti-retrovirals, specific resistance mutations have been identified in patients failing to respond to treatment with raltegravir. Although knowledge of the integrase structural biology remains fragmentary, the structures and modeling data available might provide relevant clues on the origin of the emergence of these resistance mutations. In this review, we describe the mechanism of action of this drug and the main data relating to its use in vivo, together with recent structural data important to our understanding of the origin of viral resistance.
Chemical Name: 2-(1-AMINO-1-METHYLETHYL)-N-(4-FLUOROBENZYL)-5-HYDROXY-1-METHYL-6-OXO-1,6-DIHYDROPYRIMIDINE-4-CARBOXAMIDE
Molecular Formula: C16H19FN4O3
Formula Weight: 334.35
CAS No.: 518048-03-8
Jinan Jianfeng Chemical Co.,Ltd. is a leading research-driven family-managed pharmaceutical company. In the principle of [Quality Oriented", Jianfeng passed the certification of ISO9001:2008 Quality Management System. The products meet USP, EP, JP and CP standards and are available not only in China but also in the US, Germany, Canada, Japan, etc. To meet market demands, Jianfeng set up one R&D center, two GMP workshops and three pharmaceutical & chemical factories.
"Honesty, practicality, innovation, development" are our values. Jianfeng would like to cooperate with you with high quality products and competitive price.
- Company Name: Jinan Jianfeng Chemical Co., Ltd.
- Representative: GUO CHANGBAO
- Product/Service: Apixaban , Lurasidone , Tianeptine Sodium , Febuxastat , Imatinib Mesylate , Glutathione API
- Capital (Million US $): 10000000RMB
- Year Established: 2011
- Total Annual Sales Volume (Million US $): US$2.5 Million - US$5 Million
- Export Percentage: 31% - 40%
- Total Annual Purchase Volume (Million US $): Below US$1 Million
- No. of Production Lines: 3
- No. of R&D Staff: 5 -10 People
- No. of QC Staff: 5 -10 People
- OEM Services Provided: no
- Factory Size (Sq.meters): Below 1,000 square meters
- Factory Location: Dezhou, Shandong, China
- Contact Person: Mr. Mr. Vid
- Tel: 86-531-88110457
Premium Related Products